Berdeaux, Donald MD (UIA Investigator) — Great Falls, Montana

Berdeaux, Donald MD (UIA Investigator) is a clinical research site located in Great Falls, Montana, United States 59405.

Crixeo Clinical Trials Trust Score: 27/100 (FAILING). This profile has not yet been claimed by the site owner.

Berdeaux, Donald MD (UIA Investigator) has participated in 56 clinical trials with 11 currently active.

Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Sponsors: ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Great Falls

Browse all research sites in Montana · View every site in Great Falls

Sponsor Feasibility Report

Trust Score: 27/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Berdeaux, Donald MD (UIA Investigator)?

Berdeaux, Donald MD (UIA Investigator) has a Crixeo Trust Score of 27/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Berdeaux, Donald MD (UIA Investigator) conducted?

Berdeaux, Donald MD (UIA Investigator) has 56 clinical trials on record, with 11 currently active. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Is Berdeaux, Donald MD (UIA Investigator) accredited by Crixeo Clinical Trials?

Berdeaux, Donald MD (UIA Investigator) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Berdeaux, Donald MD (UIA Investigator)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.